161 related articles for article (PubMed ID: 38930917)
21. Copper metabolism in cell death and autophagy.
Xue Q; Kang R; Klionsky DJ; Tang D; Liu J; Chen X
Autophagy; 2023 Aug; 19(8):2175-2195. PubMed ID: 37055935
[TBL] [Abstract][Full Text] [Related]
22. Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases.
Han J; Luo J; Wang C; Kapilevich L; Zhang XA
Biomed Pharmacother; 2024 May; 174():116570. PubMed ID: 38599063
[TBL] [Abstract][Full Text] [Related]
23. Cuproptosis in cancer: biological implications and therapeutic opportunities.
Li L; Zhou H; Zhang C
Cell Mol Biol Lett; 2024 Jun; 29(1):91. PubMed ID: 38918694
[TBL] [Abstract][Full Text] [Related]
24. Cuproptosis-a potential target for the treatment of osteoporosis.
Li D; Gao Z; Li Q; Liu X; Liu H
Front Endocrinol (Lausanne); 2023; 14():1135181. PubMed ID: 37214253
[TBL] [Abstract][Full Text] [Related]
25. Wilson Disease: Copper-Mediated Cuproptosis, Iron-Related Ferroptosis, and Clinical Highlights, with Comprehensive and Critical Analysis Update.
Teschke R; Eickhoff A
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731973
[TBL] [Abstract][Full Text] [Related]
26. Photoinduced Cuproptosis with Tumor-Specific for Metastasis-Inhibited Cancer Therapy.
Zheng J; Ge H; Guo M; Zhang T; Hu Q; Yao Q; Long S; Sun W; Fan J; Du J; Peng X
Small; 2024 Mar; 20(10):e2304407. PubMed ID: 37880907
[TBL] [Abstract][Full Text] [Related]
27. Carrier-Free Self-Assembly Nano-Sonosensitizers for Sonodynamic-Amplified Cuproptosis-Ferroptosis in Glioblastoma Therapy.
Zhu Y; Niu X; Ding C; Lin Y; Fang W; Yan L; Cheng J; Zou J; Tian Y; Huang W; Huang W; Pan Y; Wu T; Chen X; Kang D
Adv Sci (Weinh); 2024 Jun; 11(23):e2402516. PubMed ID: 38582500
[TBL] [Abstract][Full Text] [Related]
28. SP1/CTR1-mediated oxidative stress-induced cuproptosis in intervertebral disc degeneration.
Chen X; Li K; Xiao Y; Wu W; Lin H; Qing X; Tian S; Liu S; Feng S; Wang B; Shao Z; Peng Y
Biofactors; 2024 Apr; ():. PubMed ID: 38599595
[TBL] [Abstract][Full Text] [Related]
29. Qiju Dihuang Pill protects the lens epithelial cells via alleviating cuproptosis in diabetic cataract.
Yang J; Gao Y; Mao H; Kuang X; Tian F
J Ethnopharmacol; 2024 Jun; 333():118444. PubMed ID: 38851473
[TBL] [Abstract][Full Text] [Related]
30. Copper homeostasis and cuproptosis in health and disease.
Chen L; Min J; Wang F
Signal Transduct Target Ther; 2022 Nov; 7(1):378. PubMed ID: 36414625
[TBL] [Abstract][Full Text] [Related]
31. Elucidating cuproptosis in metabolic dysfunction-associated steatotic liver disease.
Li Y; Qi P; Song SY; Wang Y; Wang H; Cao P; Liu Y; Wang Y
Biomed Pharmacother; 2024 May; 174():116585. PubMed ID: 38615611
[TBL] [Abstract][Full Text] [Related]
32. A Self-Amplifying ROS-Responsive Nanoplatform for Simultaneous Cuproptosis and Cancer Immunotherapy.
Wu H; Zhang Z; Cao Y; Hu Y; Li Y; Zhang L; Cao X; Wen H; Zhang Y; Lv H; Jin X
Adv Sci (Weinh); 2024 Jun; 11(23):e2401047. PubMed ID: 38569217
[TBL] [Abstract][Full Text] [Related]
33. Cuproptosis as the new kryptonite of cancer: a copper-dependent novel cell death mechanism with promising implications for the treatment of hepatocellular carcinoma.
Ozkan E; Bakar-Ates F
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17663-17670. PubMed ID: 37843555
[TBL] [Abstract][Full Text] [Related]
34. Copper and Diabetes: Current Research and Prospect.
Chang W; Li P
Mol Nutr Food Res; 2023 Dec; 67(23):e2300468. PubMed ID: 37863813
[TBL] [Abstract][Full Text] [Related]
35. GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF/Cu-induced cuproptosis in myelodysplastic syndromes.
Li H; Li Y; Yu Y; Ren X; Yang C; Jin W; Li K; Zhou Y; Wu C; Shen Y; Hu W; Liu Y; Yu L; Tong X; Du J; Wang Y
Free Radic Biol Med; 2024 Jun; 222():130-148. PubMed ID: 38866192
[TBL] [Abstract][Full Text] [Related]
36. Copper Deposition in Polydopamine Nanostructure to Promote Cuproptosis by Catalytically Inhibiting Copper Exporters of Tumor Cells for Cancer Immunotherapy.
Chang J; Yin W; Zhi H; Chen S; Sun J; Zhao Y; Huang L; Xue L; Zhang X; Zhang T; Dong H; Li Y
Small; 2024 Jul; 20(27):e2308565. PubMed ID: 38339770
[TBL] [Abstract][Full Text] [Related]
37. An Enzyme-Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis-Based Synergistic Cancer Therapy.
Xu Y; Liu SY; Zeng L; Ma H; Zhang Y; Yang H; Liu Y; Fang S; Zhao J; Xu Y; Ashby CR; He Y; Dai Z; Pan Y
Adv Mater; 2022 Oct; 34(43):e2204733. PubMed ID: 36054475
[TBL] [Abstract][Full Text] [Related]
38. The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: therapeutic effects by chelators.
Zheng Y; Li XK; Wang Y; Cai L
Hemoglobin; 2008; 32(1-2):135-45. PubMed ID: 18274991
[TBL] [Abstract][Full Text] [Related]
39. Targeting cuproplasia and cuproptosis in cancer.
Tang D; Kroemer G; Kang R
Nat Rev Clin Oncol; 2024 May; 21(5):370-388. PubMed ID: 38486054
[TBL] [Abstract][Full Text] [Related]
40. Copper homeostasis and cuproptosis in cancer immunity and therapy.
Liu WQ; Lin WR; Yan L; Xu WH; Yang J
Immunol Rev; 2024 Jan; 321(1):211-227. PubMed ID: 37715546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
